Case Report
Volume 4 Issue 1 - 2021
Patient Receiving Statin Therapy Achieves an Age of 100 Years: Report of a Case
William E Feeman*
Herzzentrum Leipzig GmbH, Russenstrasse, Leipzig, Germany
*Corresponding Author: William E. Feeman, Herzzentrum Leipzig GmbH, Russenstrasse, Leipzig, Germany.
Received: November 28, 2020; Published: December 31, 2020


Patient receiving Statin Therapy Achieves an Age of 100 Years.

Introduction:   Treatment of dyslipidemia in the very old patients is, for some, an area of some controversy.  This Case Report describes an elderly gentleman aged 71 years, who was found to have dyslipidemia and  hypertension.  Additionally, he was a cigarette smoker.  His dyslipidemia was treated, as was his hypertension.  He stopped smoking cigarettes.  He has now achieved the age of 100 years, still taking his medications.

Materials and Methods: Case Report with review of medical records

Results:  The patient was treated with statins and calcium channel blockers.  He quit smoking cigarettes.  His initial statin was lovastatin and the statin was upgraded to eventual rosuvastatin in 2003.  He has been maintained on rosuvastatin since then.  The lipid results are given in the table and show that the target goal was achieved once the high-intensity statins were initiated.  At age 97 years he developed congestive heart failure, which has been treated.

Conclusions:  This case partners with a previously reported case of a 102 year old lady who was still taking her statins some 25 years after she sustained an acute myocardial infarction while seeing another physician.  The author concludes that statin therapy need not be stopped just because a patient achieves age 75 years.  (The author has numerous patients aged 75 years and older who continue to take statin therapy without adverse reactions and continue to do well.).

Keywords: Patient Receiving; Therapy Achieves


  1. Kannel WE., et al. “Factors of Risk in the Development of Coronary Heart Disease-Six-Year Follow-Up Experience”. Annals of International Medicine1 (1961): 33-47.
  2. Keys A., et al. “Probability of Middle-Aged Men Developing Coronary Heart Disease in Five Years”. Circulation 45 (1972): 815-828.
  3. Gordon T., et al. “Differences in Coronary Heart Disease in Framingham, Honolulu, and Puerto Rico”. Journal of Chronic Diseases 27 (1974): 329-344.
  4. Beaglehole R., et al. “Prevalence and Incedence Data in the Assesment of Risk of Coronary Heart Disease”. American Journal of Epidemiology1 (1975): 55-62.
  5. Stamler J., et al. “Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded? Findings in 356,222 Primary Screenees of the Multiple Risk Factor Intervention Trial. (MRFIT)”. The Journal of the American Medical Association 256 (1986): 2823-2828.
  6. The Expert Panel. “Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults”. Archives of Internal Medicine 148 (1988): 36-69.
  7. Greenland P., et al. “Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events”. The Journal of the American Medical Association 290 (2003): 891-897.
  8. Khot UN., et al. “Prevalence of Conventional Risk Factors in Patients with Coronary Heart Disease”. The Journal of the American Medical Association 290 (2003): 898-904.
  9. Nam BH., et al. “Search for an Optimal Atherogenic Lipid Risk Profile: From the Framingham Study”. The American Journal of Cardiology 97 (2006): 372-375.
  10. Feeman Jr WE. “Prediction of the Population at Risk of Atherothrombotic Disease”. Experimental and Clinical Cardiology Winter4 (2004): 235-241.
  11. Feeman Jr. WE. “Risk Factors for Atherothrombotic Disease: A Suggested Rank Order”. EC Cardology (2020).
  12. Friedewald WT., et al. “Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge”. Clinical Chemistry6 (1972): 499-502.
  13. Feeman Jr. WE. “Statin Therapy in a 102 Year Old Survivor of Myocardial Infarction Statin Therapy in Extreme Old Age”. Cardiovascular Investigations: Open Access1-3 (2017): 1-5.
Citation: William E Feeman. “Patient Receiving Statin Therapy Achieves an Age of 100 Years: Report of a Case”. EC Clinical and Medical Case Reports 4.1 (2021): 41-44.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to